A Focus Gilead challenges WHO's 'conclusive evidence' on repurposed drugs October 21st, 2020 This week, following a 30-country randomised control trial, the World Health Organisation claimed "conclusive evidence" on the effectiveness of repurposed drugs for the...
HIV/AIDS Comparable to triple therapy in women Aug 4th, 2015 Dual therapy with lopinavir/ritonavir (LPV/r) plus lamivudine (3TC) is comparable to triple therapy in women with HIV.
